UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

1. NOVEL INSIGHTS INTO THE GENETIC ETIOLOGY OF BIPOLAR DISORDER FROM A MULTI-ANCESTRY GENOME-WIDE ASSOCIATION STUDY FROM THE PSYCHIATRIC GENOMICS CONSORTIUM

European neuropsychopharmacology, 2023-10, Vol.75, p.S56-S56

Koromina, Maria

2023

Link zum Volltext

Verfügbarkeit prüfen

Discovery of new drug indications for COVID-19: A drug repurposing approach

PloS one, 2022-05, Vol.17 (5), p.e0267095

2022

Link zum Volltext

Verfügbarkeit prüfen

Delineating significant genome-wide associations of variants with antipsychotic and antidepressant treatment response: implications for clinical pharmacogenomics

Human genomics, 2020-01, Vol.14 (1), p.4-4, Article 4

2020

Link zum Volltext

Verfügbarkeit prüfen

Genome-based therapeutic interventions for β-type hemoglobinopathies

Human genomics, 2021-06, Vol.15 (1), p.32-32, Article 32

2021

Link zum Volltext

Verfügbarkeit prüfen

A novel machine learning-based approach for the computational functional assessment of pharmacogenomic variants

Human genomics, 2021-08, Vol.15 (1), p.51-51, Article 51

2021

Link zum Volltext

Verfügbarkeit prüfen

A Novel Text-Mining Approach for Retrieving Pharmacogenomics Associations From the Literature

Frontiers in pharmacology, 2020-11, Vol.11, p.602030-602030

2020

Link zum Volltext

Verfügbarkeit prüfen

Genome-wide analysis toward the epigenetic aetiology of myelodysplastic syndrome disease progression and pharmacoepigenomic basis of hypomethylating agents drug treatment response

Human genomics, 2023-04, Vol.17 (1), p.37-37, Article 37

2023

Link zum Volltext

Verfügbarkeit prüfen

Exome-Wide Analysis of the DiscovEHR Cohort Reveals Novel Candidate Pharmacogenomic Variants for Clinical Pharmacogenomics

Genes, 2020-05, Vol.11 (5), p.561

2020

Link zum Volltext

Verfügbarkeit prüfen

VARIANT TO FUNCTION: INNOVATION AND INSIGHTS FROM FINE-MAPPING AND HIGH-THROUGHPUT ASSAYS

European neuropsychopharmacology, 2023-10, Vol.75, p.S5-S5

2023

Link zum Volltext

Verfügbarkeit prüfen

Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics

Omics (Larchmont, N.Y.), 2019-11, Vol.23 (11), p.539

2019

Link zum Volltext

Verfügbarkeit prüfen

A COMPREHENSIVE STATISTICAL AND FUNCTIONAL FINE-MAPPING PIPELINE APPLIED TO BIPOLAR DISORDER GWAS RISK LOCI

European neuropsychopharmacology, 2022-10, Vol.63, p.e14

2022

Link zum Volltext

Verfügbarkeit prüfen

The ethnogeographic variability of genetic factors underlying G6PD deficiency

Pharmacological research, 2021-11, Vol.173, p.105904-105904, Article 105904

2021

Link zum Volltext

Verfügbarkeit prüfen

Development of an optimized and generic cost-utility model for analyzing genome-guided treatment data

Pharmacological research, 2022-04, Vol.178, p.106187-106187, Article 106187

2022

Link zum Volltext

Verfügbarkeit prüfen

Damaging coding variants within kainate receptor channel genes are enriched in individuals with schizophrenia, autism and intellectual disabilities

Scientific reports, 2019-12, Vol.9 (1), p.19215-11, Article 19215

2019

Link zum Volltext

Verfügbarkeit prüfen

Statistical and Functional Fine-Mapping as a Powerful Tool to Unravel the Biological Etiology of Bipolar Disorder

Biological psychiatry (1969), 2023-05, Vol.93 (9), p.S18-S18

2023

Link zum Volltext

Verfügbarkeit prüfen

Economic evaluation in psychiatric pharmacogenomics: a systematic review

The pharmacogenomics journal, 2021-08, Vol.21 (4), p.533-541

2021

Link zum Volltext

Verfügbarkeit prüfen

Identification and functional validation of novel pharmacogenomic variants using a next-generation sequencing-based approach for clinical pharmacogenomics

Pharmacological research, 2022-02, Vol.176, p.106087-106087, Article 106087

2022

Link zum Volltext

Verfügbarkeit prüfen

Discrepancies and similarities in the genome-informed guidance for psychiatric disorders amongst different regulatory bodies and research consortia using next generation sequencing-based clinical pharmacogenomics data

Pharmacological research, 2021-05, Vol.167, p.105538-105538, Article 105538

2021

Link zum Volltext

Verfügbarkeit prüfen

Documentation of clinically relevant genomic biomarker allele frequencies in the next‐generation FINDbase worldwide database

Human mutation, 2020-06, Vol.41 (6), p.1112-1122

2020

Link zum Volltext

Verfügbarkeit prüfen

A kainate receptor GluK4 deletion, protective against bipolar disorder, is associated with enhanced cognitive performance across diagnoses in the TwinsUK cohort

The world journal of biological psychiatry, 2019-05, Vol.20 (5), p.393-401

2019

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenomics variants are associated with BMI differences between individuals with bipolar and other psychiatric disorders

Pharmacogenomics, 2021-08, Vol.22 (12), p.749

2021

Link zum Volltext

Verfügbarkeit prüfen

Ethics and equity in rare disease research and healthcare

Personalized medicine, 2021-07, Vol.18 (4), p.407

2021

Link zum Volltext

Verfügbarkeit prüfen

Attitudes and Awareness Toward Pharmacogenomics and Personalized Medicine Adoption Among Health Sciences Trainees: Experience from Greece and Lessons for Europe

Omics (Larchmont, N.Y.), 2021-03, Vol.25 (3), p.190

2021

Link zum Volltext

Verfügbarkeit prüfen

Nutrigenetics and nutrigenomics: ready for clinical use or still a way to go?

Personalized medicine, 2020-05, Vol.17 (3), p.171

2020

Link zum Volltext

Verfügbarkeit prüfen

Discovery of new drug indications for COVID-19: A drug repurposing approach

PloS one, 2022-01, Vol.17 (5)

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(25)
Buchkapitel
(4)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

1. NOVEL INSIGHTS INTO THE GENETIC ETIOLOGY OF BIPOLAR DISORDER FROM A MULTI-ANCESTRY GENOME-WIDE ASSOCIATION STUDY FROM THE PSYCHIATRIC GENOMICS CONSORTIUM

Discovery of new drug indications for COVID-19: A drug repurposing approach

Delineating significant genome-wide associations of variants with antipsychotic and antidepressant treatment response: implications for clinical pharmacogenomics

Genome-based therapeutic interventions for β-type hemoglobinopathies

A novel machine learning-based approach for the computational functional assessment of pharmacogenomic variants

A Novel Text-Mining Approach for Retrieving Pharmacogenomics Associations From the Literature

Genome-wide analysis toward the epigenetic aetiology of myelodysplastic syndrome disease progression and pharmacoepigenomic basis of hypomethylating agents drug treatment response

Exome-Wide Analysis of the DiscovEHR Cohort Reveals Novel Candidate Pharmacogenomic Variants for Clinical Pharmacogenomics

VARIANT TO FUNCTION: INNOVATION AND INSIGHTS FROM FINE-MAPPING AND HIGH-THROUGHPUT ASSAYS

Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics

A COMPREHENSIVE STATISTICAL AND FUNCTIONAL FINE-MAPPING PIPELINE APPLIED TO BIPOLAR DISORDER GWAS RISK LOCI

The ethnogeographic variability of genetic factors underlying G6PD deficiency

Development of an optimized and generic cost-utility model for analyzing genome-guided treatment data

Damaging coding variants within kainate receptor channel genes are enriched in individuals with schizophrenia, autism and intellectual disabilities

Statistical and Functional Fine-Mapping as a Powerful Tool to Unravel the Biological Etiology of Bipolar Disorder

Economic evaluation in psychiatric pharmacogenomics: a systematic review

Identification and functional validation of novel pharmacogenomic variants using a next-generation sequencing-based approach for clinical pharmacogenomics

Discrepancies and similarities in the genome-informed guidance for psychiatric disorders amongst different regulatory bodies and research consortia using next generation sequencing-based clinical pharmacogenomics data

Documentation of clinically relevant genomic biomarker allele frequencies in the next‐generation FINDbase worldwide database

A kainate receptor GluK4 deletion, protective against bipolar disorder, is associated with enhanced cognitive performance across diagnoses in the TwinsUK cohort

Pharmacogenomics variants are associated with BMI differences between individuals with bipolar and other psychiatric disorders

Ethics and equity in rare disease research and healthcare

Attitudes and Awareness Toward Pharmacogenomics and Personalized Medicine Adoption Among Health Sciences Trainees: Experience from Greece and Lessons for Europe

Nutrigenetics and nutrigenomics: ready for clinical use or still a way to go?

Discovery of new drug indications for COVID-19: A drug repurposing approach

Suchergebnisse filtern